13F HOLDINGS REPORT
RTW INVESTMENTS, LP
Quarter ended Q3 2024 · Filed November 14, 2024 · Accession 0001493152-24-045409
Total Value
$6.91B
Positions
68
Other Managers
0
Confidential Omitted
No
Holdings (68)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | MADRIGAL PHARMACEUTICALS INC | MDGL | 1,993,687 | $423.1M | 6.12% |
| 2 | AXSOME THERAPEUTICS INC | AXSM | 4,189,557 | $376.5M | 5.45% |
| 3 | AVIDITY BIOSCIENCES INC | 05370A108 | 8,132,870 | $373.5M | 5.40% |
| 4 | ARGENX SE | ARGX | 654,430 | $354.8M | 5.13% |
| 5 | NATERA INC | NTRA | 2,593,323 | $329.2M | 4.76% |
| 6 | ROCKET PHARMACEUTICALS INC | RCKTW | 17,687,772 | $326.7M | 4.73% |
| 7 | PTC THERAPEUTICS INC | PTCT | 7,393,127 | $274.3M | 3.97% |
| 8 | DYNE THERAPEUTICS INC | DYN | 6,818,641 | $244.9M | 3.54% |
| 9 | PROTAGONIST THERAPEUTICS INC | PTGX | 5,426,112 | $244.2M | 3.53% |
| 10 | BRUKER CORP | BRKRP | 3,481,119 | $240.4M | 3.48% |
| 11 | INSMED INC | INSM | 3,272,008 | $238.9M | 3.46% |
| 12 | ACADIA PHARMACEUTICALS INC | ACAD | 13,707,506 | $210.8M | 3.05% |
| 13 | MERUS N V | N5749R100 | 4,169,393 | $208.3M | 3.01% |
| 14 | GERON CORP | GERN | 44,111,916 | $200.3M | 2.90% |
| 15 | MASIMO CORP | MASI | 1,462,400 | $195.0M | 2.82% |
| 16 | ALKERMES PLC | ALKS | 6,654,033 | $186.2M | 2.69% |
| 17 | AKERO THERAPEUTICS INC | 00973Y108 | 5,919,435 | $169.8M | 2.46% |
| 18 | APOGEE THERAPEUTICS INC | APGE | 2,712,096 | $159.3M | 2.31% |
| 19 | PENUMBRA INC | PEN | 795,750 | $154.6M | 2.24% |
| 20 | IMMUNOCORE HLDGS PLC | IMCR | 4,869,798 | $151.6M | 2.19% |
| 21 | CYTOKINETICS INC | CYTK | 2,721,158 | $143.7M | 2.08% |
| 22 | STRYKER CORPORATION | SYK | 396,921 | $143.4M | 2.07% |
| 23 | RADNET INC | RDNT | 1,808,604 | $125.5M | 1.82% |
| 24 | ESTABLISHMENT LABS HLDGS INC | ESTA | 2,645,703 | $114.5M | 1.66% |
| 25 | IMMATICS N.V | IMTX | 10,000,000 | $114.1M | 1.65% |
| 26 | TARSUS PHARMACEUTICALS INC | TARS | 3,412,486 | $112.2M | 1.62% |
| 27 | ULTRAGENYX PHARMACEUTICAL IN | RARE | 1,968,002 | $109.3M | 1.58% |
| 28 | SPYRE THERAPEUTICS INC | SYRE | 3,258,360 | $95.8M | 1.39% |
| 29 | CARGO THERAPEUTICS INC | 14179K101 | 4,098,955 | $75.6M | 1.09% |
| 30 | ARVINAS INC | ARVN | 2,782,329 | $68.5M | 0.99% |
| 31 | STOKE THERAPEUTICS INC | STOK | 4,652,285 | $57.2M | 0.83% |
| 32 | 89BIO INC | 282559103 | 7,378,548 | $54.6M | 0.79% |
| 33 | CG ONCOLOGY INC | CGON | 1,344,074 | $50.7M | 0.73% |
| 34 | GLAUKOS CORP | GKOS | 386,291 | $50.3M | 0.73% |
| 35 | UROGEN PHARMA LTD | URGN | 3,787,347 | $48.1M | 0.70% |
| 36 | NEUROGENE INC | NGNE | 1,135,256 | $47.6M | 0.69% |
| 37 | ORUKA THERAPEUTICS INC | ORKA | 1,850,648 | $45.4M | 0.66% |
| 38 | ORCHESTRA BIOMED HLDGS INC | OBIO | 8,206,159 | $42.2M | 0.61% |
| 39 | SAGE THERAPEUTICS INC | 78667J108 | 5,591,700 | $40.4M | 0.58% |
| 40 | TAYSHA GENE THERAPIES INC | TSHA | 14,946,420 | $30.0M | 0.43% |
| 41 | CULLINAN THERAPEUTICS INC | CGEM | 1,705,960 | $28.6M | 0.41% |
| 42 | TEMPUS AI INC | TEM | 400,000 | $22.6M | 0.33% |
| 43 | GH RESEARCH PLC | GHRS | 3,327,129 | $22.3M | 0.32% |
| 44 | LENZ THERAPEUTICS INC | LENZ | 863,389 | $20.5M | 0.30% |
| 45 | ESSA PHARMA INC | 29668H708 | 3,261,496 | $19.8M | 0.29% |
| 46 | TOURMALINE BIO INC | 89157D105 | 741,656 | $19.1M | 0.28% |
| 47 | DIANTHUS THERAPEUTICS INC | DNTH | 666,667 | $18.3M | 0.26% |
| 48 | ROIVANT SCIENCES LTD | ROIV | 1,454,273 | $16.8M | 0.24% |
| 49 | BIOAGE LABS INC | BIOA | 786,353 | $16.4M | 0.24% |
| 50 | REPLIMUNE GROUP INC | REPL | 1,133,787 | $12.4M | 0.18% |
| 51 | XENCOR INC | XNCR | 575,000 | $11.6M | 0.17% |
| 52 | 10X GENOMICS INC | TXG | 502,856 | $11.4M | 0.16% |
| 53 | IMMUNIC INC | IMUX | 4,567,717 | $7.5M | 0.11% |
| 54 | PERCEPTIVE CAP SOLUTIONS COR | G70077105 | 742,500 | $7.4M | 0.11% |
| 55 | WAVE LIFE SCIENCES LTD | WVE | 900,000 | $7.4M | 0.11% |
| 56 | IDEAYA BIOSCIENCES INC | IDYA | 200,000 | $6.3M | 0.09% |
| 57 | STRUCTURE THERAPEUTICS INC | GPCR | 125,000 | $5.5M | 0.08% |
| 58 | MILESTONE PHARMACEUTICALS IN | MIST | 3,256,102 | $4.9M | 0.07% |
| 59 | ACELYRIN INC | 00445A100 | 978,310 | $4.8M | 0.07% |
| 60 | EXAGEN INC | XGN | 1,511,866 | $4.7M | 0.07% |
| 61 | REGENXBIO INC | RGNX | 350,000 | $3.7M | 0.05% |
| 62 | ARTIVA BIOTHERAPEUTICS INC | ARTV | 148,844 | $2.3M | 0.03% |
| 63 | ALLURION TECHNOLOGIES INC | ALURW | 3,697,549 | $2.3M | 0.03% |
| 64 | SAB BIOTHERAPEUTICS INC | SABSW | 635,276 | $1.7M | 0.02% |
| 65 | CENTESSA PHARMACEUTICALS PLC | CNTA | 50,000 | $799,500 | 0.01% |
| 66 | ADAGIO MED HLDGS INC | 00534B100 | 209,361 | $540,151 | 0.01% |
| 67 | UNIQURE NV | QURE | 10,000 | $49,300 | 0.00% |
| 68 | ROCKET PHARMACEUTICALS INC | RCKTW | 350,000 | $22,575 | 0.00% |